Significant decline in subarachnoid hemorrhage hospitalizations due to COVID-19

New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic. The rate of Subarachnoid hemorrhage (SAH) – bleeding in the space between the brain and the tissue covering the brain – hospitalizations declined 22.5 percent during the study period,…

Details

Study identifies possible COVID-19 drugs — including several that are FDA-approved

PHILADELPHIA – A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. The team, whose findings were published in Cell Reports, screened thousands of existing…

Details